Get the Stockscreener App
192.25
0.34%
-0.725
Overview
News
Price History
Option Chain
Financials
Why ABBV Down?
Discussions
Forecast
Dividend History
Abbvie Inc stock is traded at $192.25, with a volume of 633.11K.
It is down -0.34% in the last 24 hours and up +7.12% over the past month.
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).
See More
Previous Close:
$192.97
Open:
$193.16
24h Volume:
633.11K
Relative Volume:
0.11
Market Cap:
$341.01B
Revenue:
$56.33B
Net Income/Loss:
$4.28B
P/E Ratio:
80.10
EPS:
2.4
Net Cash Flow:
$15.62B
1W Performance:
+4.57%
1M Performance:
+7.12%
6M Performance:
+2.56%
1Y Performance:
+9.89%
1-Day Range:
$192.14
$193.86
1-Week Range:
$182.15
$194.49
52-Week Range:
$153.58
$207.32
Abbvie Inc Stock (ABBV) Company Profile
Name
Abbvie Inc
Sector
Industry
Phone
(847) 932-7900
Address
1 NORTH WAUKEGAN ROAD, NORTH CHICAGO, IL
Compare ABBV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ABBV
Abbvie Inc
|
192.37 | 341.01B | 56.33B | 4.28B | 15.62B | 2.40 |
|
LLY
Lilly Eli Co
|
880.32 | 827.20B | 40.86B | 8.37B | -2.28B | 9.25 |
|
NVO
Novo Nordisk Adr
|
87.22 | 386.95B | 42.09B | 14.65B | 10.11B | 3.2833 |
|
JNJ
Johnson Johnson
|
153.88 | 344.63B | 88.82B | 14.07B | 19.03B | 5.79 |
|
MRK
Merck Co Inc
|
88.31 | 251.88B | 64.17B | 17.12B | 14.84B | 6.7297 |
Abbvie Inc Stock (ABBV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-10-24 | Resumed | BofA Securities | Neutral |
| Dec-05-24 | Downgrade | Daiwa Securities | Outperform → Neutral |
| Nov-22-24 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Nov-15-24 | Initiated | Wolfe Research | Outperform |
| Nov-04-24 | Upgrade | Argus | Hold → Buy |
| Oct-17-24 | Initiated | Bernstein | Mkt Perform |
| Jun-05-24 | Upgrade | HSBC Securities | Hold → Buy |
| May-17-24 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-29-24 | Upgrade | William Blair | Mkt Perform → Outperform |
| Dec-18-23 | Downgrade | HSBC Securities | Buy → Hold |
| Dec-11-23 | Upgrade | Goldman | Neutral → Buy |
| Nov-09-23 | Initiated | Deutsche Bank | Hold |
| Oct-30-23 | Upgrade | Barclays | Equal Weight → Overweight |
| Oct-20-23 | Resumed | UBS | Neutral |
| Sep-29-23 | Initiated | Raymond James | Outperform |
| Jul-25-23 | Initiated | William Blair | Mkt Perform |
| Jul-14-23 | Initiated | HSBC Securities | Buy |
| Apr-05-23 | Downgrade | Argus | Buy → Hold |
| Mar-01-23 | Initiated | Guggenheim | Buy |
| Feb-22-23 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Feb-10-23 | Upgrade | SVB Securities | Underperform → Market Perform |
| Nov-18-22 | Initiated | Credit Suisse | Outperform |
| Nov-08-22 | Downgrade | Societe Generale | Buy → Hold |
| Aug-01-22 | Downgrade | Atlantic Equities | Overweight → Neutral |
| May-23-22 | Initiated | SVB Leerink | Underperform |
| May-06-22 | Downgrade | Daiwa Securities | Outperform → Neutral |
| Apr-06-22 | Resumed | Morgan Stanley | Overweight |
| Feb-28-22 | Downgrade | UBS | Buy → Neutral |
| Feb-03-22 | Reiterated | BMO Capital Markets | Outperform |
| Feb-03-22 | Reiterated | Barclays | Equal Weight |
| Feb-03-22 | Reiterated | BofA Securities | Neutral |
| Feb-03-22 | Reiterated | Goldman | Neutral |
| Jan-13-22 | Initiated | Redburn | Buy |
| Jan-12-22 | Reiterated | BMO Capital Markets | Outperform |
| Dec-09-21 | Resumed | Wells Fargo | Overweight |
| Nov-23-21 | Upgrade | Societe Generale | Hold → Buy |
| Jul-27-21 | Resumed | Truist | Buy |
| Apr-07-21 | Resumed | RBC Capital Mkts | Outperform |
| Nov-10-20 | Resumed | Bernstein | Outperform |
| Sep-29-20 | Initiated | Berenberg | Hold |
| Jun-23-20 | Upgrade | Atlantic Equities | Neutral → Overweight |
| Jun-09-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jun-02-20 | Upgrade | Argus | Hold → Buy |
| May-18-20 | Resumed | BofA/Merrill | Neutral |
| May-12-20 | Upgrade | JP Morgan | Neutral → Overweight |
| May-11-20 | Resumed | Morgan Stanley | Overweight |
| Apr-20-20 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Mar-23-20 | Downgrade | Societe Generale | Buy → Hold |
| Feb-27-20 | Initiated | Barclays | Equal Weight |
| Feb-06-20 | Initiated | Mizuho | Buy |
| Jan-07-20 | Initiated | RBC Capital Mkts | Sector Perform |
| Dec-26-19 | Reiterated | Cowen | Outperform |
| Sep-26-19 | Upgrade | Citigroup | Neutral → Buy |
| Aug-20-19 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Jun-27-19 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Jun-26-19 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| May-28-19 | Initiated | Goldman | Neutral |
| Apr-29-19 | Upgrade | BMO Capital Markets | Underperform → Market Perform |
View All
Abbvie Inc Stock (ABBV) Latest News
Abbvie 4Q Results - Contract Pharma
AbbVie Inc. (NYSE:ABBV) is Slocum Gordon & Co LLP's 5th Largest Position - MarketBeat
Sumitomo Mitsui DS Asset Management Company Ltd Has $46.07 Million Position in AbbVie Inc. (NYSE:ABBV) - MarketBeat
Telos Capital Management Inc. Sells 1,380 Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat
The Zacks Analyst Blog Walmart, Visa, AbbVie and AstroNova - Zacks Investment Research
Investors Buy High Volume of AbbVie Call Options (NYSE:ABBV) - MarketBeat
Earnings Season Scorecard and Fresh Research Reports for Walmart, Visa & AbbVie - Yahoo Finance
3 Top AI-Powered Biotech Stocks to Buy in February - The Motley Fool
Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know - Yahoo Finance
Allergan Aesthetics Invites Consumers to Join the Faces of Natrelle® Campaign - AbbVie
Brandywine Oak Private Wealth LLC Sells 1,465 Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat
AbbVie Inc. (NYSE:ABBV) Shares Purchased by Tyche Wealth Partners LLC - MarketBeat
AbbVie secures $3 billion credit facility, total access now $8 billion - Investing.com
Medicare Part D Redesign: More Firms See New Discounts Offsetting Spending Cap Benefit - Citeline News & Insights
Abbvie Entered Revolving Credit Facility Up To $3 Billion Maturing In 2030 -February 05, 2025 at 04:24 pm EST - Marketscreener.com
Jim Cramer Says AbbVie Inc. (ABBV) Is A ‘Buy’ - Insider Monkey
AbbVie Rises 8% Since Q4 Earnings: Buy, Hold Or Sell The Stock? - Barchart
AbbVie Rises 8% Since Q4 Earnings: Buy, Hold or Sell the Stock? - Yahoo Finance
Jim Cramer’s Stock Picks: Why AbbVie is a Must-Buy Right Now! - Mi Valle
AbbVie Inc. (NYSE:ABBV) Shares Purchased by Choreo LLC - MarketBeat
AbbVie Inc. (NYSE:ABBV) Position Boosted by Tectonic Advisors LLC - MarketBeat
Jim Cramer: This Health Care Stock Is A 'Winner,' Buy Bitcoin Instead Of Coinbase - Benzinga
Mirae Asset Global Investments Co. Ltd. Buys 149,048 Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat
Sargent Investment Group LLC Sells 10,876 Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat
Is Wall Street Bullish or Bearish on AbbVie Stock? - Nasdaq
Is Wall Street Bullish Or Bearish On AbbVie Stock? - Barchart
Concord Asset Management LLC VA Acquires 1,550 Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat
AbbVie (NYSE:ABBV) Trading Down 0.1%What's Next? - MarketBeat
Analysts reset AbbVie stock price target after earnings - TheStreet
AbbVie Inc. (NYSE:ABBV) is Welch Group LLC's 9th Largest Position - MarketBeat
Daiwa Securities Adjusts Price Target on AbbVie to $190 From $180, Keeps Neutral Rating - Marketscreener.com
Rockline Wealth Management LLC Has $5.69 Million Stock Holdings in AbbVie Inc. (NYSE:ABBV) - MarketBeat
Cullinan Associates Inc. Decreases Position in AbbVie Inc. (NYSE:ABBV) - MarketBeat
Columbus Macro LLC Buys 29,524 Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat
abrdn plc Cuts Position in AbbVie Inc. (NYSE:ABBV) - MarketBeat
Beyond Market Price: Uncovering AbbVie Inc's Intrinsic Value - GuruFocus.com
AbbVie Inc. (NYSE:ABBV) Shares Bought by Waldron Private Wealth LLC - MarketBeat
AbbVie's SWOT analysis: stock outlook strong despite humira loss - MSN
Independence Bank of Kentucky Increases Stock Position in AbbVie Inc. (NYSE:ABBV) - MarketBeat
Chicago Partners Investment Group LLC Grows Stock Holdings in AbbVie Inc. (NYSE:ABBV) - MarketBeat
China Universal Asset Management Co. Ltd. Grows Holdings in AbbVie Inc. (NYSE:ABBV) - MarketBeat
AbbVie Stock Soars as Biotech Tops Sales Estimates, Raises Outlook - MSN
Healthcare Powerhouses Join TriSalus Board: Ex-Fresenius CEO and AbbVie Oncology Pioneer Unite - StockTitan
AbbVie (NYSE:ABBV) Price Target Raised to $215.00 - MarketBeat
AbbVie (NYSE:ABBV) Price Target Raised to $217.00 - MarketBeat
Looking At AbbVie's Recent Unusual Options Activity - Benzinga
Nike To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Monday - Benzinga
Idexx Stock, AbbVie, and Molina Buck Downward Tariff Trend. These Are Today’s Top S&P 500 Performers. - MSN
UBS Group Increases AbbVie (NYSE:ABBV) Price Target to $190.00 - MarketBeat
AbbVie (NYSE:ABBV) Shares Up 2.6% on Analyst Upgrade - MarketBeat
AbbVie (NYSE:ABBV) Price Target Raised to $210.00 at Wells Fargo & Company - MarketBeat
Abbvie Inc Stock (ABBV) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.19%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):